SCHEMBL530979

SCHEMBL530979

COc1ccc(CSCCCCCCCCCCCCSCCCCCCCCCCCC(=O)O)cc1

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 1/20 0.54
ALDH1A1 P00352 2/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
PKM P14618 1/20 0.51
LTB4R Q15722 1/20 0.48
CYP2C19 P33261 1/20 0.47
PLA2G4B P0C869 2/20 0.47
FFAR1 O14842 3/20 0.47
PPARG P37231 1/20 0.45
PPARD Q03181 1/20 0.45
PPARA Q07869 1/20 0.45
EPHX1 P07099 1/20 0.45
KDM4E B2RXH2 1/20 0.43
POLB P06746 1/20 0.43
GAA P10253 1/20 0.43
PTGFR P43088 1/20 0.43
LDHA P00338 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8003157 0.86 CYP2C19 (0.64) PDE4BALDH1A1SMN1; SMN2PKMCYP2C19
SCHEMBL17045908 0.84 ALDH1A1 (0.55) ALDH1A1SMN1; SMN2PKMPOLBGAA
SCHEMBL17045933 0.82 HDAC1 (0.59) ALDH1A1SMN1; SMN2PKM
SCHEMBL530937 0.80 IDO1 (0.47) ALDH1A1SMN1; SMN2PKMGAA
SCHEMBL13067926 0.80 IDO1 (0.47) ALDH1A1SMN1; SMN2PKMGAA
SCHEMBL5180355 0.80 CYP2C19 (0.54) ALDH1A1SMN1; SMN2PKMCYP2C19FFAR1
SCHEMBL3938443 0.80 CYP2C19 (0.73) ALDH1A1SMN1; SMN2LTB4RCYP2C19FFAR1
SCHEMBL1585162 0.80 CYP2C19 (0.73) ALDH1A1SMN1; SMN2LTB4RCYP2C19FFAR1
SCHEMBL19756295 0.79 ALDH1A1 (0.50) PDE4BALDH1A1CYP2C19PLA2G4BPOLB
SCHEMBL9663959 0.79 LTB4R (0.69) PDE4BLTB4RFFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1610126-B1 A system for determining the electrical potential across a membrane UNIV CALIFORNIA (US) 2014-04-30 EP disclosed
EP-1409456-B1 DETECTION OF TRANSMEMBRANE POTENTIALS BY OPTICAL METHODS UNIV CALIFORNIA (US) 2012-02-08 EP disclosed
EP-0977035-B2 A system for determining the electrical potential across a membrane UNIV CALIFORNIA (US) 2010-07-21 EP disclosed
US-7687282-B2 Detection of transmembrane potentials by optical methods THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-03-30 US disclosed
US-7173130-B2 Detection of transmembrane potentials by optical methods THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2007-02-06 US disclosed
US-20070026384-A1 Detection of transmembrane potentials by optical methods THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2007-02-01 US disclosed
US-7118899-B2 Detection of transmembrane potentials by optical methods THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2006-10-10 US disclosed
US-7115401-B2 Detection of transmembrane potentials by optical methods THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2006-10-03 US disclosed
US-7087416-B2 Detection of transmembrane potentials by optical methods THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2006-08-08 US disclosed
EP-1610126-A1 A system for determining the electrical potential across a membrane THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2005-12-28 EP disclosed
US-6596522-B2 Compositions and optical methods for determining transmembrane potentials across plasma membrane of biological cells THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2003-07-22 US disclosed
US-20030129670-A1 Detection of transmembrane potentials by optical methods THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2003-07-10 US disclosed
US-20020164577-A1 Detection of transmembrane potentials by optical methods THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2002-11-07 US disclosed
US-20020137201-A1 DETECTION OF TRANSMEMBRANE POTENTIALS BY OPTICAL METHODS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2002-09-26 US disclosed
US-6342379-B1 Detection of transmembrane potentials by optical methods THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2002-01-29 US disclosed
US-6107066-A Detection of transmembrane potentials by optical methods THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2000-08-22 US disclosed
EP-0977035-A2 A system for determining the electrical potential across a membrane REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2000-02-02 EP disclosed
EP-0834074-B1 DETECTION OF TRANSMEMBRANE POTENTIALS BY OPTICAL METHODS UNIV CALIFORNIA (US) 1999-11-03 EP disclosed
EP-0834074-A1 DETECTION OF TRANSMEMBRANE POTENTIALS BY OPTICAL METHODS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1998-04-08 EP disclosed
WO-1996041166-A2 DETECTION OF TRANSMEMBRANE POTENTIALS BY OPTICAL METHODS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1996-12-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070026384-A1 Detection of transmembrane potentials by optical methods MBOAT1, TRPM4, NME4 PDE4B 1821/4885ALDH1A1 2425/4885SMN1; SMN2 4297/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.